Pharmaceuticals News and Research

RSS

Book on the effects of antibiotic-resistant microbes

In RISING PLAGUE: THE GLOBAL THREAT FROM DEADLY BACTERIA AND OUR DWINDLING ARSENAL TO FIGHT THEM (Prometheus Books, $26), Dr. Brad Spellberg-an infectious diseases specialist and member of a national task force charged with attacking antibiotic resistant infections-tells the story of this potentially grave public health crisis.

18 Sep 2009

New tool developed to provide precise and cost-effective data collection for drug discovery efforts

Cancer and cell biology experts at the University of Cincinnati (UC) have developed a new mass spectrometry-based tool they say provides more precise, cost-effective data collection for drug discovery efforts.

18 Sep 2009

Drugs industry names the contraceptive pill as the greatest pharmacy innovation of the past 150 years

The Contraceptive Pill has been crowned the greatest pharmacy innovation of the past 150 years, by leading figures in the drugs industry.

18 Sep 2009

HTDS update on its H1N1 project status

HTDS- The Company is pleased to provide the following update to its shareholders and followers on the (H1N1) Vaccine for Mellow Hope Inc, its China based subsidiary; and other general business matters.

18 Sep 2009

Merck, Wellcome Trust to launch vaccine center in India to produce vaccines for developing countries

Pharmaceutical company Merck and the Wellcome Trust have joined together to create a non-profit, £90-million (about $150 million) research center in India to facilitate the development of new vaccines, "including [those for] neglected diseases for which inadequate or no vaccines exist," Nature News reports.

18 Sep 2009

China SFDA approves clinical trial of China Aoxing's abuse resistant opioid drug

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").

17 Sep 2009

A not-for-profit mission from Wellcome Trust and Merck to develop affordable vaccines for low-income countries

The Wellcome Trust and Merck & Co., Inc. today announced the creation of the MSD Wellcome Trust Hilleman Laboratories (www.hillemanlaboratories.in), the first of its kind research and development joint venture with a not-for-profit mission to focus on developing affordable vaccines to prevent diseases that commonly affect low-income countries.

17 Sep 2009

CEO Cancer Gold Standard accreditation for Meridian Health

Meridian Health has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

17 Sep 2009

FDA: Manufacturers to include warning of promethazine hydrochloride injection on labels

The U.S. Food and Drug Administration is telling manufacturers of the drug promethazine to include a boxed warning regarding the injectable form of the drug.

17 Sep 2009

Canada's health care associations urge health ministers to tackle pressing issues at the ministers' annual meeting

Canada's leading health care associations are calling on federal and provincial/territorial health ministers to tackle a number of pressing issues at the ministers' annual meeting, taking place in Winnipeg September 17.

17 Sep 2009

LAB Research signs exclusive agreement to extend Korean market

LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has extended its Korean market coverage through a new exclusive agency agreement with Safe Chemicals Co., LTD., a South Korea based consulting company ("Safe Chemicals").

17 Sep 2009

DDI Predict 2009 edition assessing the risk of potential drug-drug interactions released

Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces today the release of the 2009 Edition of DDI Predict. This innovative software application adds a number of enhancements to assess the risk of potential drug-drug interactions including those involving multiple enzymatic pathways.

17 Sep 2009

GENova Biotherapeutics signs collaboration deal with Beckpharma

GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed a collaboration deal with Beckpharma Ltd.

17 Sep 2009

PCMA to support Chairman Baucus’ efforts to find common ground and advance bipartisan legislation

“PCMA supports Chairman Baucus’ continuing efforts to find common ground and advance bipartisan legislation. We look forward to reviewing Chairman Baucus’ proposal in greater detail and working constructively with the Finance Committee.

17 Sep 2009

Glaxo conceals risks: Antidepressant drug Paxil causes birth defects

Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.

17 Sep 2009

USPTO issues a Notice of Allowance for Milestone's drug delivery system patent application

Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for Milestone's U.S. patent application, titled "Computer Controlled Drug Delivery System with Dynamic Pressure Sensing."

17 Sep 2009

Electronic filing format to improve accuracy of registrations and drug listings

The U.S. Food and Drug Administration (FDA) now requires that establishment registration and drug listing information be filed in electronic format.

17 Sep 2009

Three senior analysts appointed by Jefferies for healthcare equity research

Jefferies today announced the expansion of its Healthcare Equity Research effort with the hiring of three senior analysts. Corey Davis, PhD has joined as a Managing Director covering Specialty Pharmaceuticals, Thomas Wei will join next month as a Managing Director covering Biotechnology, and Jon Davis Wood will join later this month as a Senior Vice President covering Life Sciences Tools. All three professionals will be based in New York.

17 Sep 2009

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

Bayer HealthCare today announced that data from more than 30 clinical trials evaluating three products in the company's oncology portfolio - Nexavar(R) (sorafenib) tablets, regorafenib (BAY 73-4506) and Alpharadin(TM) - will be presented at the joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress, September 20-24, 2009 in Berlin, Germany.

17 Sep 2009

Mechanism of action of the anti-cancer drug GMX1778 identified

Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced a new study has been published identifying the mechanism of action of the anti-cancer drug GMX1778. Co-authored by scientists at Gemin X Pharmaceuticals and Metabolon, the paper “The Small Molecule GMX1778 is a Potent Inhibitor of NAD+ Biosynthesis: Strategy for Enhanced Therapy in NAPRT1-Deficient Tumors” appears online ahead of print in Molecular and Cellular Biology.

17 Sep 2009

Pharmaceuticals News and Research

Book on the effects of antibiotic-resistant microbes

New tool developed to provide precise and cost-effective data collection for drug discovery efforts

Drugs industry names the contraceptive pill as the greatest pharmacy innovation of the past 150 years

HTDS update on its H1N1 project status

Merck, Wellcome Trust to launch vaccine center in India to produce vaccines for developing countries

China SFDA approves clinical trial of China Aoxing's abuse resistant opioid drug

A not-for-profit mission from Wellcome Trust and Merck to develop affordable vaccines for low-income countries

CEO Cancer Gold Standard accreditation for Meridian Health

FDA: Manufacturers to include warning of promethazine hydrochloride injection on labels

Canada's health care associations urge health ministers to tackle pressing issues at the ministers' annual meeting

LAB Research signs exclusive agreement to extend Korean market

DDI Predict 2009 edition assessing the risk of potential drug-drug interactions released

GENova Biotherapeutics signs collaboration deal with Beckpharma

PCMA to support Chairman Baucus’ efforts to find common ground and advance bipartisan legislation

Glaxo conceals risks: Antidepressant drug Paxil causes birth defects

USPTO issues a Notice of Allowance for Milestone's drug delivery system patent application

Electronic filing format to improve accuracy of registrations and drug listings

Three senior analysts appointed by Jefferies for healthcare equity research

Bayer HealthCare to present its clinical trial data at a joint Multidisciplinary Congress

Mechanism of action of the anti-cancer drug GMX1778 identified

Event guide: World ADC London eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring